Literature DB >> 17990983

Fasting in healthy subjects is associated with intrahepatic accumulation of lipids as assessed by 1H-magnetic resonance spectroscopy.

Louise Moller1, Hans Stodkilde-Jorgensen, Finn T Jensen, Jens O L Jorgensen.   

Abstract

The impact of fasting on IHL (intrahepatic lipid) content in human subjects has not been investigated previously, but results indicate that it may change rapidly in response to metabolic cues. The aim of the present study was to measure IHL content after fasting and to correlate this with circulating lipid intermediates. A total of eight healthy non-obese young males were studied before and after 12 or 36 h of fasting. IHL content was assessed by (1)H-magnetic resonance spectroscopy, and blood samples were drawn after the fasting period. IHL content increased significantly after the 36 h fasting period [median increase 156% (range, 4-252%); P<0.05]. Furthermore, a significant positive correlation between this increase and 3-hydroxybutyrate concentration was detected (P=0.03). No significant change in IHL content was demonstrated after the 12 h fasting period. The baseline median inter-individual variation in IHLs was 0.51% (range, 0.25-0.72%). The coefficient of variation of IHL measurements was 11.6%; 25-30% of the variation was of analytical origin and the remaining 70-75% was attributed to repositioning. In conclusion, IHL content increases in healthy male subjects during fasting, which demonstrates that nutritional status should be accounted for when assessing IHLs in clinical studies. Moreover, the increase in IHLs was positively correlated with the concentration of 3-hydroxybutyrate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17990983     DOI: 10.1042/CS20070217

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  21 in total

1.  A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.

Authors:  Sarah E Hugo; Lourdes Cruz-Garcia; Santhosh Karanth; Ryan M Anderson; Didier Y R Stainier; Amnon Schlegel
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  In reply.

Authors:  Johannes Weiß; Monika Rau; Andreas Geier
Journal:  Dtsch Arztebl Int       Date:  2015-02-27       Impact factor: 5.594

3.  Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome.

Authors:  Anne Grethe Schioldan; Søren Gregersen; Stine Hald; Ann Bjørnshave; Mette Bohl; Bolette Hartmann; Jens Juul Holst; Hans Stødkilde-Jørgensen; Kjeld Hermansen
Journal:  Eur J Nutr       Date:  2017-01-09       Impact factor: 5.614

4.  Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets.

Authors:  D M Faleck; K Ali; R Roat; M J Graham; R M Crooke; R Battisti; E Garcia; R S Ahima; Y Imai
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-18       Impact factor: 4.310

5.  Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.

Authors:  Kevin C Corbit; Camella G Wilson; Dylan Lowe; Jennifer L Tran; Nicholas B Vera; Michelle Clasquin; Aras N Mattis; Ethan J Weiss
Journal:  JCI Insight       Date:  2019-08-08

6.  Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice.

Authors:  S M Turpin; A J Hoy; R D Brown; C Garcia Rudaz; J Honeyman; M Matzaris; M J Watt
Journal:  Diabetologia       Date:  2010-09-15       Impact factor: 10.122

7.  Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.

Authors:  James P Warne; Jillian M Varonin; Sofie S Nielsen; Louise E Olofsson; Christopher B Kaelin; Streamson Chua; Gregory S Barsh; Suneil K Koliwad; Allison W Xu
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

8.  LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes.

Authors:  Allyson N Hamlin; Joshua E Basford; Anja Jaeschke; David Y Hui
Journal:  J Biol Chem       Date:  2016-06-17       Impact factor: 5.157

Review 9.  Intermittent Energy Restriction, Weight Loss and Cardiometabolic Risk: A Critical Appraisal of Evidence in Humans.

Authors:  Alexia L Katsarou; Nicholas L Katsilambros; Chrysi C Koliaki
Journal:  Healthcare (Basel)       Date:  2021-04-22

10.  High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

Authors:  Morten M Poulsen; Poul F Vestergaard; Berthil F Clasen; Yulia Radko; Lars P Christensen; Hans Stødkilde-Jørgensen; Niels Møller; Niels Jessen; Steen B Pedersen; Jens Otto L Jørgensen
Journal:  Diabetes       Date:  2012-11-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.